Filing Details
- Accession Number:
- 0001140361-16-089899
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2016-12-15 20:48:23
- Reporting Period:
- 2016-12-13
- Filing Date:
- 2016-12-15
- Accepted Time:
- 2016-12-15 20:48:23
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
1367644 | Emergent Biosolutions Inc. | EBS | Pharmaceutical Preparations (2834) | 141902018 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1380177 | Ronald Richard | 400 Professional Dr, Suite 400 Gaithersburg MD 20879 | Yes | No | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Acquisiton | 2016-08-01 | 152 | $0.00 | 19,870 | No | 4 | J | Direct | |
Common Stock | Acquisiton | 2016-08-01 | 604 | $0.00 | 20,474 | No | 4 | J | Direct | |
Common Stock | Acquisiton | 2016-08-01 | 577 | $0.00 | 21,051 | No | 4 | J | Direct | |
Common Stock | Disposition | 2016-12-13 | 5,800 | $34.09 | 15,251 | No | 4 | S | Direct | |
Common Stock | Disposition | 2016-12-13 | 100 | $34.06 | 15,151 | No | 4 | S | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | J | Direct | |
No | 4 | J | Direct | |
No | 4 | J | Direct | |
No | 4 | S | Direct | |
No | 4 | S | Direct |
Footnotes
- In connection with the spin-off (the "Spin-off") of Aptevo Therapeutics Inc. from Emergent BioSolutions Inc. ("Emergent"), on August 1, 2016 the reporting person received a grant of restricted stock units as a result of an adjustment to an existing Emergent restricted stock unit grant held by the reporting person prior to the Spin-off. The restricted stock units vest in May 2017.
- In connection with the spin-off (the "Spin-off") of Aptevo Therapeutics Inc. from Emergent BioSolutions Inc. ("Emergent"), on August 1, 2016 the reporting person received a grant of restricted stock units as a result of an adjustment to an existing Emergent restricted stock unit grant held by the reporting person prior to the Spin-off. The restricted stock units vest in May 2017 and May 2018.
- In connection with the spin-off (the "Spin-off") of Aptevo Therapeutics Inc. from Emergent BioSolutions Inc. ("Emergent"), on August 1, 2016 the reporting person received a grant of restricted stock units as a result of an adjustment to an existing Emergent restricted stock unit grant held by the reporting person prior to the Spin-off. The restricted stock units vest in May 2017, May 2018 and May 2019.